Company intelligence / Profile preview

3A BIOTECH

Ownership: Private
Development stage: Other

Overview

3A BIOTECH is a Spanish biotechnology company specializing in the development and manufacture of preservatives, antioxidants, and functional ingredients for human and animal nutrition as well as cosmetics, nutraceuticals, agriculture, paints/inks, and biodiesel. Their portfolio includes both synthetic and natural “clean label” solutions. Notable innovations include postbiotic-enriched products such as Bioprotect RT (with reuterin from Lactobacillus reuteri) targeting Salmonella control in pet foods[1], as well as antifungal formulations derived from Propionibacterium acidipropionici fermentation. The company emphasizes sustainability by using local waste by-products in its bioprocesses[1][2].

Modalities: Bioactive compoundProbiotic-derived productNatural preservativeSynthetic additive
Industry: Non-Drug Biotech

Beyond the preview

Go deeper on 3A BIOTECH.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on 3A BIOTECH.

Explore the full profile